Biotin amelioration of nephrotoxicity in streptozotocin-induced diabetic mice

Saudi Journal of Biological Sciences

Volumn 22, Issue 5, 2015, Pages 564-569

  Aldahmash, Badr A ^a   El Nagar, Doaa M ^b   Ibrahim, Khalid E ^a   Metwaly, Mahmoud S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Biotin; Diabetes; Mice; Nephroprotective; Oxidative damage; Streptozotocin

Indexed keywords

MUS;

EID: 84939254967     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2015.03.003     Document Type: Article

References (42)

1. Al-Qudah K., Ismail Z.B. The relationship between serum biotin and oxidant/antioxidant activities in bovine lameness. Res. Vet. Sci. 2012, 92:138-141.
2. Arora S., Ojha S., Vohora D. Characterization of Streptozotocin Induced Diabetes Mellitus in Swiss Albino Mice. Glob. J. Pharmacol. 2009, 3:81-84.
3. Báez-Saldaña A., Zendejas-Ruiz I., Revilla-Monsalve C., Islas-Andrade S., Cárdenas A., Rojas-Ochoa A., Vilches A., Fernandez-Mejia C. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Am. J. Clin. Nutr. 2004, 79:238-243.
4. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
5. Bojestig M., Arnqvist H.J., Hermansson G., Karlberg B.E., Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1994, 330:15-18.
6. Casey G.R., Joyce M., Nagle R.G., Chen G., Hayes D. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease. Surg. Res. 2004, 123:176-181.
7. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004, 65:116-128.
8. Chow F., Nikolic-Paterson D., Ozols E., Atkins R., Tesch G. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. Am. Soc. Nephrol. 2005, 16:1711-1722.
9. Esterbauer H., Schaur J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
10. Fernandez-Mejia C. Pharmacological effects of biotin. J. Nutr. Biochem. 2005, 16:424-427.
11. Fiume M.Z. Final report on the safety assessment of biotin. Int. J. Toxicol. 2001, 20(Suppl. 4):1-12.
12. Foulis A.K. The pathogenesis of β-cell destruction in Type 1 (insulin-dependent) diabetes mellitus. Pathology 1987, 152:141-148.
13. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000, 23:542-549.
14. Gojo A., Utsunomiya K., Taniguchi K., Yokota T., Ishizawa S., Kanazawa Y., Kurata H., Tajima N. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur. J. Pharm. 2007, 568:242-247.
15. Gravel R.A., Narang M.A. Molecular genetics of biotin metabolism: old vitamin, new science. Nutr. Biochem. J. 2005, 16:428-431.
16. Hassan Y.I., Zempleni J. Epigenetic regulation of chromatin structure and gene function by biotin. Nutrition 2006, 136:1763-1765.
17. Kiran G., Nandini C., Ramesh H., Salimath P. Progression of early phase diabetic nephropathy in STZ-induced diabetic rats: evaluation of various kidney-related parameters. Ind. J. Exp. Biol. 2012, 50:133-140.
18. Kolb H., Kroneke D. IDDM: lessons from the low dose Streptozotocin model in mice. Diabetes Rev. 1993, 1:116-126.
19. Krolewski M., Eggers P.W., Warram J.H. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 1996, 50:2041-2046.
20. Lan H.Y., Paterson D.J., Atkins R.C. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int. 1991, 40:425-433.
21. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417.
22. Locatelli F., Canaud B., Eckardt K.U., Stenvinkel P., Wanner C., Zoccali C. The importance of diabetic nephropathy in current nephrological practice. Nephrol. Dial. Transplant. 2003, 18:1716-1725.
23. Mock D.M., Quirk J.G., Mock N.I. Marginal biotin deficiency during normal pregnancy. Am. J. Clin. Nutr. 2002, 75:295-299.
24. Mohamed A.K., Bierhaus A., Schiekofer S., Tristschler H., Ziegler H., Nawroth P.P. The role of oxidative stress and NF-β activation in late diabetic complication. Biofactors 1999, 10:171-179.
25. Nammi S., Boini M.K., Lodagala D.S., Behara R.B. The juice of fresh leaves of Catharanthus roseus Linn reduces blood glucose in normal and alloxan diabetic rats. BMC Compl. Altern. Med. 2003, 3:1-4.
26. Nikolic-Paterson D.J., Atkins R.C. The role of macrophages in glomerulonephritis. Nephrol. Dial. Transplant. 2001, 16(Suppl 5):3-7.
27. Pacheco-Alvarez D., Solórzano-Vargas R.S., Del Río A.L. Biotin in metabolism and its relationship to human disease. Arch. Med. Res. 2002, 33:439-447.
28. Reddi A., De Angelis B., Frank O., Lasker N., Baker H. Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice. Life Sci. 1988, 42:1323-1330.
29. Romero M., Yao L., Sridhar S., Bhatta A., Dou H., Ramesh G., Brands M., Pollock D., Caldwell R., Cederbaum S., Head C., Bagi Z., Lucas R., Caldwell R. l-Citrulline protects from kidney damage in type 1 diabetic mice. Front. Immunol. 2013, 10.3389/fimmu.2013.00480.
30. Said H.M. Biotin: the forgotten vitamin. Am. J. Clin. Nutr. 2002, 75:179-180.
31. Sassy-Prigent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., Bariety J., Bruneval P. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000, 49:466-475.
32. Seghrouchni I., Drai J., Bannier E., Rivière J., Calmard P., Garcia I., Orgiazzi J., Revol A. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta 2002, 321:89-96.
33. Spencer M., Mühlfeld A., Segererd S., Hudkins K., Erik E., LeBoeuf R., Alpers C. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice. Am. J. Nephrol. 2004, 24:20-31.
34. Svensson M., Sundkvist G., Arnqvist H.J., Bjork E., Blohme G., Bolinder J., Henricsson M., Nystrom L., Torffvit O., Waernbaum I., Ostman J., Eriksson J.W. Diabetes Incidence Study in Sweden (DISS): signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003, 26:2903-2909.
35. Szabo C. Roles of poly (ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res. 2005, 52:60-67.
36. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 1999, 9:109-113.
37. Wada J., Zhang H., Tsuchiyama Y., Hiragushi K., Hida K., Shikata K., Kanwar Y., Makino H. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int. 2001, 59:1363-1373.
38. Wild S., Roglic K., Green A., Sicree R., King H. Global prevalence of diabetes, estimation for the year 2003 and projections for 2030. Diabetes Care 2003, 27:1047-1053.
39. Yamamoto Y., Kato I., Doi T., Yonekura H., Ohashi S., Takeuchi M., Watanabe T., Yamagishi S., Sakurai S., Takasawa S., Okamoto H., Yamamoto H. Development and prevention of advanced diabetic nephropathy in RAGE-over expressing mice. Am. Soc. Clin. Inves. 2001, 108:261-268.
40. Yang N., Wu L., Nikolic-Paterson D., Ng Y., Yang W., Mu W., Gilbert R., Cooper M., Atkins R., Lan H. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol. Dial. Transplant. 1998, 13:1967-1974.
41. Yoshikawa H., Tajiri Y., Sako Y., Hashimoto T., Umeda F., Nawata H. Effects of biotin on glucotoxicity or lipotoxicity in rat pancreatic islets. Metabolism 2002, 51:163-168.
42. Zafar M., Naqvi S., Ahmed M., Kaimkhani Z. Altered kidney morphology and enzymes in streptozotocin induced diabetic rats. Int. J. Morphol. 2009, 27:783-790.